BlackRock’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $657K | Sell |
165,446
-451,178
| -73% | -$1.79M | ﹤0.01% | 4310 |
|
|
2025
Q1 | $4.3M | Buy |
616,624
+13,047
| +2% | +$91.1K | ﹤0.01% | 3657 |
|
|
2024
Q4 | $8.84M | Buy |
603,577
+198,805
| +49% | +$2.91M | ﹤0.01% | 3443 |
|
|
2024
Q3 | $7.75M | Buy |
404,772
+8,499
| +2% | +$163K | ﹤0.01% | 3490 |
|
|
2024
Q2 | $6.98M | Buy |
+396,273
| New | +$6.98M | ﹤0.01% | 3516 |
|